INTRODUCTION
============

Fat mass and obesity-associated (FTO) gene is located on chromosome 16 in humans, FTO helps to regulate energy homeostasis by controlling energy expenditure ([@b2-molce-43-058]). In 2007, several independent genome-wide association studies and population-based approaches confirmed that associations exist between single nucleotide polymorphisms (SNP) in intron 1 of FTO and obesity ([@b3-molce-43-058]; [@b30-molce-43-058]). Expression of FTO is high in the early stage of adipogenesis and declines during later stages ([@b34-molce-43-058]). FTO modulates oxidative stress and the pathogenesis of non-alcoholic fatty liver disease by increasing lipid deposition in liver cells ([@b6-molce-43-058]). However, the role of FTO in osteogenic differentiation is unknown.

A variety of complex signaling pathways regulate osteogenic differentiation ([@b17-molce-43-058]; [@b33-molce-43-058]). Bone morphogenetic proteins (BMPs) are multifunctional proteins that induce osteogenic differentiation and play important roles in various cellular functions, including signal transduction, development, cell growth and repair of bone fractures ([@b1-molce-43-058]; [@b31-molce-43-058]). BMP2 enhances expression of transcription factors such as distal-less homeobox5 (Dlx5) and runt-related transcription factor 2 (Runx2) ([@b11-molce-43-058]; [@b12-molce-43-058]).

Adenosine monophosphate-activated protein kinase (AMPK) is a heterotrimeric enzyme complex composed of a catalytic (α) subunit and two regulatory (β and γsubunits) ([@b24-molce-43-058]). AMPK regulates energy homeostasis and is ubiquitously expressed ([@b15-molce-43-058]). Activation of AMPK induces osteogenic differentiation via induction of Dlx5-dependent Runx2 expression ([@b11-molce-43-058]). Consistently, we previously reported that piperine induces osteogenic differentiation via activation of AMPK ([@b16-molce-43-058]). An association between AMPK signaling and endoplasmic reticulum (ER) stress has also been reported ([@b14-molce-43-058]; [@b18-molce-43-058]).

The ER is vital for synthesis, localization, folding, and secretion of proteins ([@b4-molce-43-058]). Additionally, ER stress plays an important role in signaling that underlies-metabolism, differentiation, and apoptosis of mammalian cells ([@b5-molce-43-058]; [@b25-molce-43-058]). Mild ER stress positively regulates osteogenic differentiation ([@b9-molce-43-058]; [@b21-molce-43-058]; [@b28-molce-43-058]); however, tunicamycin (TM) induces severe ER stress by stimulating the unfolded protein response, which results in cellular dysfunction ([@b21-molce-43-058]). C/EBP homologous protein (CHOP), a marker of ER stress, induces FTO expression in hepatocytes ([@b22-molce-43-058]). However, the relationship between FTO expression and ER stress in osteoblasts is unknown.

This study demonstrates that BMP2 induces FTO expression by activating AMPK. Thereafter, FTO increases expression of osteogenic genes by inducing mild ER stress.

MATERIALS AND METHODS
=====================

Reagents
--------

Dulbecco's modified Eagle medium (DMEM), phosphate-buffered saline, penicillin-streptomycin, and 0.25% trypsin-EDTA were purchased from Gibco-BRL (USA). Fetal bovine serum (FBS) was purchased from MP Biomedicals (Korea). Compound C was purchased from Abcam (USA). Emerald Amp GRPCR Master Mix was purchased from Takara (Japan), and AmpiGene qPCR Green Mix Hi-ROX was purchased from Enzo (USA). Recombinant human BMP2 was purchased from Cowellmedi (Korea). Antibodies against BMP2, FTO, CHOP, ATF4 and β-actin were obtained from Santa Cruz Biotechnology (USA). Antibodies against AMPK and phospho-AMPK (p-AMPK) were purchased from Cell Signaling Technology (USA). Antibodies against Dlx5 were purchased from Abcam.

Cell culture
------------

The mouse mesenchymal stem cell line C3H10T1/2 (American Type Culture Collection \[ATCC\], USA) was maintained in DMEM containing 10% FBS, 100 units/ml penicillin and 100 mg/ml streptomycin in humidified air containing 5% CO~2~ at 37°C. Differentiation of osteoblasts was induced by the addition of osteogenic medium containing 0.25 g/ml BMP2. The culture medium was replaced every 2 days.

Reverse-transcriptase polymerase chain reaction (RT-PCR) and real-time PCR analysis
-----------------------------------------------------------------------------------

Total RNA was isolated from cells using TRIzol reagent (BioScience Technology, Korea) according to the manufacturer's instructions. Reverse transcription was performed using 5 μg of total RNA. RT-PCR conditions included initial denaturation at 95°C for 5 min followed by a three-step cycle of denaturation at 95°C for 30 s, annealing at the optimal temperature for each primer pair for 30 s, and extension at 72°C for 30 s. After 25 to 35 cycles, a final extension was performed at 72°C for 5 min. The RT-PCR primer sequences were as follows: β-actin forward, 5′-GACTACCTCATGAAGATC-3′; β-actin reverse, 5′-GATCCACCTCTGCTGGAA-3′; Dlx5 forward, 5′-CAGAAGAGTCCCAAGCATCC-3′; Dlx5 reverse, 5′-GAGCGCTTTGCCATAAGAAG-3′; Runx2 forward, 5′-CCGCACGACAACCGCACCAT-3′; Runx2 reverse, 5′-CGCTCCGGCCCACAAATCTC-3′; FTO forward, 5′-GCGATGATGAAGTGGACCTT-3′; FTO reverse, 5′-GCAGTCTCCCTGGTGAAGAG-3′; CHOP forward, 5′-GTCCAGCTGGGAGCTGGAAG-3′; CHOP reverse, 5′-CTGACTGGAATCTGGAGAG-3′; ATF4 forward, 5′-GGACAGATTGGATGTTGGAGAAAATG-3′; ATF4 reverse, 5′-GGAGATGGCCAATTGGGTTCAC-3′. The real-time PCR sequence was as follows: β-actin forward, 5′-TCCTACAATGAGCTGCGTGTG-3′; β-actin reverse, 5′-GGGGTGTTGAAGGTCTCAAA-3′; Dlx5 forward, 5′-GCCCACCAACCAGCCAGAGA-3′; Dlx5 reverse, 5′-GCGAGGTACTGAGTCTTCTGAAACC-3′; Runx2 forward, 5′-AGATGACATCCCCATCCATC-3′; Runx2 reverse, 5′-GTGAGGGATGAAATGCTGG-3′; FTO forward, 5′-CCGTCCTGCGATGATGAAGT-3′; FTO reverse, 5′-CCCATGCCGAAATAGGGCTC-3′. Expression levels were normalized to those of endogenous β-actin and data were analyzed using the ^ΔΔ-^C~T~ method ([@b29-molce-43-058]).

Transient transfection and luciferase assay
-------------------------------------------

C3H10T1/2 cells were transiently transfected with the indicated plasmids using Lipofectamine 2000 (Invitrogen, USA) as described previously ([@b29-molce-43-058]). Subsequently, the cells were harvested with 0.25 μg/ml BMP2 following 24 h of transfection and assayed using the luciferase reporter assay system (Promega, USA). As an internal control, cytomegalovirus β-galactosidase plasmid was co-transfected into each transfection experiment, and luciferase activity was normalized to the β-galactosidase activity. To confirm the effects of AMPK activation, cells were transfected with FTO-Luc vector using the Lipofectamine 2000. Firefly and renilla luciferase activities were determined using the Dual-Luciferase Reporter Assay System (Promega, Germany).

Silencing of FTO
----------------

The siRNAs for FTO were synthesized chemically (Bioneer, Korea), deprotected, annealed, and prepared for transfection according to the manufacturer's instructions. C3H10T1/2 cells were transfected with the siRNAs using Lipofectamine 2000. The siRNA sequences were as follows: siFTO sense 5′-CUCACAGCCUCGGUUUAGU-3′; siFTO antisense 5′-ACUAAACCGAGGCUGUGAG-3′.

Alkaline phosphatase (ALP) staining
-----------------------------------

For ALP staining, C3H10T1/2 cells were cultured with BMP2 (0.25 μg/ml) and siFTO (200 nM) for 4 days. Staining was performed using standard protocols. Briefly, cultured cells were fixed with 10% formaldehyde, rinsed twice with deionized water, and treated with BCIP/NBT solution (Sigma Aldrich, USA) for 15 min. Following additional washing with phosphate-buffered saline, densitometry analysis was performed out on stained cultures using Image J.

Western blot analysis
---------------------

Cells were harvested using the EzRIPA lysis kit (ATTO Technology, Japan) and centrifuged at 12,000*g* for 10 min at 4°C. Total protein was quantified using the Bradford assay, separated by SDS-PAGE, and transferred to a polyvinylidene difluoride membrane. After blocking in 5% skimmed milk prepared in Tris-buffered saline containing Tween 20, the membrane was incubated with specific primary antibodies (1:5,000). Signals were detected using ECL reagent (Advansta, USA). Densitometric analysis of the blotted membrane was performed using a FUSION solo analyzer system (Vilber Lourmat, Germany).

Statistical analysis
--------------------

All experiments were repeated at least three times. Data analysis was performed using GraphPad Prism 5 (GraphPad Software, USA). Statistical analysis was performed using the Student's *t*-test or ANOVA, followed by Dimcam's multiple comparison tests. *P* values \< 0.05 were considered significant. Results are expressed as the mean ± SEM of triplicate independent samples.

RESULTS
=======

BMP2 treatment increases FTO expression in C3H10T1/2 cells
----------------------------------------------------------

To investigate the expression of FTO during osteogenic differentiation, we treated C3H10T1/2 cells with 0.125 or 0.25 μg/ml BMP2. RT-PCR and real-time PCR analyses demonstrated that BMP2 treatment significantly increased mRNA expression of FTO in a dose-dependent manner ([Figs. 1A and 1B](#f1-molce-43-058){ref-type="fig"}). Moreover, BMP2 treatment increased mRNA expression of FTO in a time-dependent manner ([Figs. 1C and 1D](#f1-molce-43-058){ref-type="fig"}). Western blot analysis indicated that BMP2 treatment-induced protein expression of FTO in a dose-dependent ([Fig. 1E](#f1-molce-43-058){ref-type="fig"}) and time-dependent ([Fig. 1F](#f1-molce-43-058){ref-type="fig"}). These results demonstrate that BMP2 induces FTO expression in C3H10T1/2 cells.

Overexpression of FTO upregulates the osteogenic genes Dlx5 and Runx2 in C3H10T1/2 cells
----------------------------------------------------------------------------------------

To characterize the role of FTO in osteogenic differentiation, we transfected C3H10T1/2 cells with a plasmid harboring FTO (pCMV-FTO). RT-PCR and real-time PCR analyses showed that overexpression of FTO significantly increased mRNA expression of Dlx5 and Runx2 ([Figs. 2A and 2B](#f2-molce-43-058){ref-type="fig"}). Western blot analysis indicated that overexpression of FTO increased protein expression of Runx2 ([Fig. 2C](#f2-molce-43-058){ref-type="fig"}). We performed ALP staining to investigate the effect of FTO on ALP activity. ALP activity was significantly increased by FTO overexpression in the BMP2 group compared with that observed in BMP2 group alone ([Fig. 2D](#f2-molce-43-058){ref-type="fig"}). These results strongly suggest that FTO positively regulates osteogenic differentiation.

Knockdown of FTO attenuates BMP2-induced upregulation of the osteogenic gene Runx2 in C3H10T1/2 cells
-----------------------------------------------------------------------------------------------------

To further investigate the role of FTO in osteogenic differentiation, we transfected C3H10T1/2 cells with FTO-targeting siRNA (siFTO). Knockdown of FTO attenuated the BMP2-induced increases in mRNA expression ([Figs. 3A and 3B](#f3-molce-43-058){ref-type="fig"}) and protein expression ([Fig. 3C](#f3-molce-43-058){ref-type="fig"}) of Runx2. ALP staining was performed to confirm that knockdown of FTO perturbed osteogenic differentiation. This demonstrated that knockdown of FTO attenuated the BMP2-induced increase in ALP activity ([Fig. 3D](#f3-molce-43-058){ref-type="fig"}). Taken together, these results strongly suggest that FTO positively regulates osteogenic differentiation by modulating Runx2 expression and ALP activity.

p-AMPK upregulates FTO in C3H10T1/2 cells
-----------------------------------------

We next investigated whether AMPK-regulates FTO expression in C3H10T1/2 cells. RT-PCR and western blot analyses demonstrated that transfection of pcDNA3.0-cmyc-mAMPK-a312, which harbored a constitutively active form of AMPK (CA-AMPK), increased mRNA expression ([Fig. 4A](#f4-molce-43-058){ref-type="fig"}) and protein expression ([Fig. 4B](#f4-molce-43-058){ref-type="fig"}). Inhibition of AMPK activity using compound C (Com.C) attenuated BMP2-induced upregulation of FTO and p-AMPK ([Figs. 4C and 4D](#f4-molce-43-058){ref-type="fig"}). ALP staining was performed to investigate if activation of AMPK affected osteogenic differentiation. This demonstrated that the expression of CA-AMPK increased ALP activity ([Fig. 4E](#f4-molce-43-058){ref-type="fig"}). Additionally, treatment with Com.C attenuated BMP2-induced ALP activity ([Fig. 4F](#f4-molce-43-058){ref-type="fig"}). Furthermore, FTO-luc activity is increased by BMP2 or CA-AMPK but decreases with Com.C ([Fig. 4G](#f4-molce-43-058){ref-type="fig"}). Thus, AMPK upregulates FTO.

FTO induces phosphorylation of AMPK in C3H10T1/2 cells
------------------------------------------------------

Next, we determined if FTO directly activates AMPK in C3H10T1/2 cells. Overexpression of FTO increased phosphorylation of AMPK ([Fig. 5A](#f5-molce-43-058){ref-type="fig"}), Consistently, knockdown of FTO abrogated BMP2-induced phosphorylation of AMPK ([Fig. 5B](#f5-molce-43-058){ref-type="fig"}).

FTO and p-AMPK induce mild ER stress
------------------------------------

Mild ER stress induces osteogenic differentiation ([@b23-molce-43-058]; [@b28-molce-43-058]). BMP2 treatment induced mild ER stress in C3H10T1/2 cells this effect was attenuated by knockdown of FTO or treatment with Com.C ([Fig. 6A](#f6-molce-43-058){ref-type="fig"}) Thus, we speculated that FTO and p-AMPK induce mild ER stress in C3H10T1/2 cells. To investigate this, we transfected C3H10T1/2 cells with pCMV-FTO in the presence or absence of Com.C. Expression of ATF4 and CHOP was increased upon transfection of pCMV-FTO and this effect were attenuated in the presence of Com.C ([Figs. 6B and 6D](#f6-molce-43-058){ref-type="fig"}). Additionally, expression of ATF4 and CHOP was increased upon transfection of pc-DNA3.0-AMPK and this effect was attenuated by knockdown of FTO ([Figs. 6C and 6E](#f6-molce-43-058){ref-type="fig"}). These results suggest that pAMPK and FTO stimulate osteogenic differentiation by inducing mild ER stress.

Severe ER stress prevents BMP2-induced upregulation of FTO and p-AMPK
---------------------------------------------------------------------

TM strongly induces ER stress ([@b10-molce-43-058]; [@b21-molce-43-058]). To investigate whether severe ER stress perturbs BMP2-induced upregulation of FTO and p-AMPK, we compared BMP2-induced expression of FTO and p-AMPK in the absence and presence of TM. RT-PCR analysis revealed that TM treatment increased mRNA expression of CHOP but decreased that of FTO ([Fig. 7A](#f7-molce-43-058){ref-type="fig"}). Western blot analysis demonstrated that TM treatment abrogated the BMP2 induced increase in p-AMPK ([Fig. 7B](#f7-molce-43-058){ref-type="fig"}). ALP staining confirmed that TM treatment attenuated the BMP2-induced increase in ALP activity ([Fig. 7C](#f7-molce-43-058){ref-type="fig"}).

DISCUSSION
==========

Previously reported that that FTO-knock out mice display postnatal growth retardation, which manifests as reduced body weight and bone mineral density ([@b7-molce-43-058]); however, the molecular mechanism by which FTO stimulates osteogenic differentiation remains unknown. Here, we demonstrate for the first time that FTO stimulates osteogenic differentiation by inducing mild ER stress. The results of the current study illustrate one mechanism underlying the role of FTO in osteogenic differentiation.

A relationship between FTO and AMPK has been previously reported ([@b26-molce-43-058]; [@b32-molce-43-058]). One study demonstrated that AMPK decreases lipid accumulation in skeletal muscle cells by suppressing FTO expression ([@b32-molce-43-058]). Another study revealed that knockdown of FTO reduces phosphorylation of AMPK in Alzheimer's disease ([@b26-molce-43-058]). The current study demonstrated that activation of AMPK markedly increased expression of FTO and that a positive feedback loop existed between FTO and p-AMPK in C3H10T1/2 cells ([Figs. 4](#f4-molce-43-058){ref-type="fig"} and [5](#f5-molce-43-058){ref-type="fig"}). However, other tissues have not yet studied positive feedback between FTO and p-AMPK. Therefore, our results in osteoblasts can be highly appreciated.

In osteoblasts, mild ER stress is important for differentiation ([@b9-molce-43-058]; [@b23-molce-43-058]; [@b28-molce-43-058]) but inhibited by severe ER stress ([@b10-molce-43-058]; [@b8-molce-43-058]). FTO increases CHOP and other ER stress markers in hepatocyte ([@b22-molce-43-058]). The current study demonstrated that FTO and p-AMPK stimulated osteogenic differentiation by inducing mild ER stress and that induction of severe ER stress upon the application of TM reduced FTO expression and AMPK activation. These results demonstrate that FTO and AMPK are important regulators of osteogenic differentiation induced by mild ER stress and that a positive feedback loop exists between FTO and p-AMPK. In addition, ER stress may be a therapeutic target for the development of drugs to treat bone disorders such as osteoarthritis. Specifically, it may be possible to halt osteogenic differentiation before activation of the positive feedback loop between p-AMPK and FTO by targeting the mechanisms underlying ER stress.

In addition, FTO is a demethylase that was first reported to catalyze the oxidative demethylation of N^6^-methyladenosine (m^6^A) in mRNA ([@b13-molce-43-058]). Our results show that the expression of FTO induces mild ER stress. The mechanism between demethylation of FTO and mild ER stress has not been reported yet. However, several studies have reported that ER stress genes altered DNA and histone methylation patterns in or near the promoters of these genes ([@b19-molce-43-058]; [@b20-molce-43-058]; [@b27-molce-43-058]). Thus, we consider that FTO, an m^6^A demethylase, regulates demethylation in promoters of ER stress genes.

In summary, FTO induces osteogenic differentiation of C3H10T1/2 cells via a positive feedback loop with p-AMPK. FTO and p-AMPK stimulate osteogenic differentiation by inducing mild ER stress; however, TM-induced severe ER stress suppresses FTO expression and AMPK activation ([Fig. 7D](#f7-molce-43-058){ref-type="fig"}).
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![BMP2 treatment induces FTO expression in C3H10T1/2 cells\
(A and B) RT-PCR and real-time PCR analyses were performed using total RNA isolated from C3H10T1/2 cells treated with BMP2 (+, 0.125 μg/ml; ++, 0.25 μg/ml) for 1 day. (C and D) RT-PCR and real-time PCR analyses were performed using total RNA isolated from C3H10T1/2 cells treated with 0.25 μg/ml BMP2 for 12 or 24 h. (E and F) C3H10T1/2 cells were treated with BMP2 for the indicated durations and harvested for western blot analysis using the indicated antibodies. \**P* \< 0.05, \*\**P* \< 0.001, and \*\*\**P* \< 0.005 compared with untreated control cells. Data represent the mean ± SEM of three individual experiments. All experiments were independently repeated at least three times.](molce-43-058f1){#f1-molce-43-058}

![Overexpression of FTO induces osteogenic differentiation of C3H10T1/2 cells\
(A--C) C3H10T1/2 cells were transfected with pcDNA3.1 (2 μg) or pCMV-FTO (+, 1 μg; ++, 2 μg) for 6 h and treated with BMP2 (0.25 μg/ml) for 1 day. (A) RT-PCR analysis was performed using total RNA isolated from cells and primers targeting FTO, Dlx5, Runx2, and β-actin. (B) Real-time PCR was performed using total RNA isolated from cells. (C) Western blot analysis was performed using the indicated antibodies. (D) C3H10T1/2 cells were transfected with pCMV-FTO (+, 0.2 μg; ++, 0.4 μg) or treated with BMP2 (0.25 μg/ml) for 4 days. \**P* \< 0.05, \*\**P* \< 0.001, and \*\*\**P* \< 0.005 compared with untreated control cells. Data represent the mean ± SEM of three individual experiments. All experiments were independently repeated at least three times.](molce-43-058f2){#f2-molce-43-058}

![Knock-down of FTO attenuates BMP2-induced osteogenic differentiation of C3H10T1/2 cells\
C3H10T1/2 cells were transfected with siFTO (+, 100 nM; ++, 200 nM) for 6 h and then treated with BMP2 (0.25 μg/ml) for 1 day. (A) RT-PCR analysis was performed using total RNA isolated from cells. (B) The real-time PCR analysis was performed using total RNA isolated from cells. (C) Western blot analysis was performed using the indicated antibodies. (D) C3H10T1/2 cells were transfected with siFTO for 6 h and then treated with BMP2 (0.25 μg/ml) for 4 days. ALP staining was performed. All experiments were independently repeated at least three times. Data represent the mean ± SEM of three individual experiments. \**P* \< 0.05 and \*\**P* \< 0.001 compared with untreated control cells. ^\#^*P* \< 0.05, ^\#\#^*P* \< 0.01, and ^\#\#\#^*P* \< 0.005 compared with BMP2 treatment cells. All experiments were independently repeated at least three times.](molce-43-058f3){#f3-molce-43-058}

![Activation of AMPK enhances FTO expression in C3H10T1/2 cells\
(A and B) C3H10T1/2 cells were transfected with pcDNA3.0-AMPK (2 μg) for 6 h and then incubated for a further 12 h. (A) RT-PCR analysis was performed using total RNA extracted from cells. (B) Western blot analysis was performed using the indicated antibodies. (C and D) C3H10T1/2 cells were treated with BMP2 (0.25 μg/ml) for 24 h. Com.C (+, 0.1 μM; ++, 1 μM) was added 3 h prior to harvest. (C) RT-PCR analysis was performed using total RNA extracted from cells. (D) Western blot analysis was performed using the indicated antibodies. (E) C3H10T1/2 cells were transiently transfected with pc-DNA3.0AMPK (0.4 μg/well) and/or treated with BMP2 (0.25 μg/ml) for 4 days, and then stained with BCIP/NBT liquid substrate. \*\**P* \< 0.001 compared with untreated control cells. ^\#^*P* \< 0.05 compared with CA-AMPK transfected cells. (F) C3H10T1/2 cells were treated with or without BMP2 (0.25 μg/ml) in the presence of Com.C (1 μM) for 4 days and then ALP staining was performed. \**P* \< 0.05 compared with untreated control cells. ^\#^*P* \< 0.05 compared with BMP2 treated cells. (G) C3H10T1/2 cells were transfected with FTO-Luc (2 μg), pc-DNA3.0-AMPK (2 μg) and b-galactosidase plasmids. After 24 h, cultures were treated with BMP2 (0.25 μg/ml) or Com.C (1 μM) for 48 h. Luciferase activity was measured and presented as the mean ± SEM of individual experiments. \*\*\**P* \< 0.005 compared with untreated control cells. ^&&&^*P* \< 0.005 compared with BMP2 treated cells. ^\#\#\#^*P* \< 0.005 compared with pc-DNA-3.0-AMPK-transfected cells. All experiments were independently repeated at least three times.](molce-43-058f4){#f4-molce-43-058}

![FTO induces phosphorylation of AMPK in C3H10T1/2 cells\
(A) C3H10T1/2 cells were transfected with pCMV-FTO (2 μg) for 6 h and then incubated for a further 12 h. Western blot assay analysis was performed using the indicated antibodies. (B) C3H10T1/2 cells were transfected with siFTO for 6 h and then treated with BMP2 (0.25 μg/ml) for 12 h. Western blot analysis was performed using the indicated antibodies. All experiments were independently repeated at least three times.](molce-43-058f5){#f5-molce-43-058}

![FTO and p-AMPK induce mild ER stress\
(A) C3H10T1/2 cells were transfected with siFTO for 6 h and then treated with BMP2 (0.25 μg/ml) and Com.C (1 μM) for 1 day. RT-PCR was performed using total RNA isolated from cells. (B and D) C3H10T1/2 cells were transfected with pCMV-FTO (2 μg) for 6 h and then treated with Com.C (1 μM) for 24 h. (C and E) C3H10T1/2 cells were transfected with pc-DNA3.0-AMPK (2 μg) and siFTO for 6 h and then incubated for a further 12 h. RT-PCR (B and C) and western blot (D and E) analyses of ER stress markers (ATF4 and CHOP) were performed. All experiments were independently repeated at least three times.](molce-43-058f6){#f6-molce-43-058}

![Severe ER stress induced by TM abrogates BMP2-induced upregulation of FTO and p-AMPK\
(A) C3H10T1/2 cells were treated with BMP2 (0.25 μg/ml) and/or TM (100 ng/ml) for 24 h. RT-PCR was performed using total RNA isolated from cells. (B) C3H10T1/2 cells were treated with BMP2 (0.25 μg/ml) and/or TM (100 ng/ml) for 12 h. Western blotting was performed with the indicated antibodies. (C) C3H10T1/2 cells were treated with BMP2 (0.25 μg/ml) and/or TM (100 ng/ml) for 4 days. ALP staining was performed. \*\**P* \< 0.001 compared with untreated control cells. ^\#\#^*P* \< 0.001 compared with BMP2 treated cells. All experiments were independently repeated at least three times. (D) FTO induces osteogenic differentiation of C3H10T1/2 cells via a positive feedback loop with p-AMPK. FTO and p-AMPK stimulate osteogenic differentiation by inducing mild ER stress; however, TM-induced severe ER stress suppresses FTO expression and AMPK activation.](molce-43-058f7){#f7-molce-43-058}
